Physician profile
Kari Dailey
NPI 1972320893
$960.36
in general payments reported to CMS, 2019-2025
16 companies · $705 in 2025
The $705 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $256 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $279.06 | 2024-2025 | General - Therapies |
| Biotronik INC. | $130.21 | 2025 | Solia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.67 | 2024-2025 | Lifevest |
| Novo Nordisk INC | $93.16 | 2024-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $59.47 | 2025 | Farxiga |
| Bridgebio Pharma, INC. | $45.26 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $43.54 | 2025 | |
| Alnylam Pharmaceuticals INC. | $34.02 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $32.88 | 2024-2025 | Verquvo |
| Chiesi USA, INC. | $28.57 | 2025 | Kengreal, Cleviprex |
| Integra Lifesciences Corporation | $24.15 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kiniksa Pharmaceuticals International, Plc | $18.39 | 2024 | Arcalyst |
| Pfizer INC. | $16.47 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.45 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $14.04 | 2025 | Uptravi, Opsynvi, Opsumit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivaquant INC, Dba Rhythm Express | $11.02 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.